Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

CRUCELL KONDIGT PER.C6-LICENTIEOVEREENKOMST

4 Posts
| Omlaag ↓
  1. [verwijderd] 15 maart 2007 14:09
    Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health




    Leiden, The Netherlands, March 15, 2007- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and Pfizer Animal Health today announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's industry-leading PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.

4 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 910,26 +0,74%
EUR/USD 1,0842 -0,05%
FTSE 100 8.293,55 +0,22%
Germany40^ 18.635,10 +0,74%
Gold spot 2.326,31 -0,05%
NY-Nasdaq Composite 16.735,02 -0,01%

Stijgers

VIVORY...
+16,70%
JDE PE...
+3,76%
JUST E...
+3,41%
Air Fr...
+3,15%
SIGNIF...
+2,81%

Dalers

DSM FI...
-3,27%
Basic-Fit
-2,58%
Kendrion
-1,86%
EXOR NV
-1,85%
Vastned
-1,63%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links